Coya Therapeutics
-
Coya Therapeutics, Dr Reddy’s Laboratories collaborate for investigational combination therapy to treat ALS
Coya retains the right to commercialise COYA 302 for patients with amyotrophic lateral sclerosis (ALS) in Japan, Mexico, and each…
Read More » -
Coya Therapeutics secures global deal with Dr Reddy’s Laboratories
Coya has received an exclusive, royalty-bearing license to sell Dr Reddy’s proposed biosimilar Abatacept in several regions Coya Therapeutics has…
Read More »